Navigation Links
Microbia Names John McCarthy to Senior Management Team
Date:8/5/2009

Microbia, Inc. (Microbia), an emerging leader in the production of sustainable, specialty ingredients and biomaterials from fermentation technology, has appointed John A. McCarthy Jr. as Senior Vice President Corporate Strategy and Chief Financial Officer. Mr. McCarthy will play a key role for Microbia as the company prepares to introduce its line of natural carotenoid products for the human and animal food ingredient and nutritional supplement markets early next year. For more information about Microbia, please go to www.microbia.com.

Lexington, MA (PRWEB) -- Microbia, Inc. (Microbia), an emerging leader in the production of sustainable, specialty ingredients and biomaterials from fermentation technology, has appointed John A. McCarthy Jr. as Senior Vice President Corporate Strategy and Chief Financial Officer. Mr. McCarthy will have broad responsibility for corporate strategic planning, finance, human resources, corporate communications and information technology as the company prepares to introduce its line of natural carotenoid products for the human and animal food ingredient and nutritional supplement markets early next year.

"Microbia is very pleased to welcome John to the senior management team," stated Richard Bailey, Ph.D., Microbia's President and Chief Executive Officer. "John's extraordinary track record of success in the transformation and growth of science-based companies from research and development-focused organizations to broad commercial entities will be vital as we accelerate our plans to take advantage of the large-scale market opportunities afforded by our technologies."

"I'm very pleased to be joining Microbia at this important time in its development," stated Mr. McCarthy. "The ability to build a unique, low-cost and highly valuable specialty biochemicals franchise based on renewable raw materials presents a tremendous market opportunity for the company, its customers and our environment."

John McCarthy brings 17 years of executive management experience to Microbia from the broad healthcare and alternative energy industries, including having led three IPOs, numerous corporate partnerships, and the raising of over $1 billion of capital in the private and public markets. Most recently, he served as Executive Vice President and Chief Financial Officer of Verenium Corporation, a publicly traded leader in the biofuels industry. At Verenium, Mr. McCarthy was responsible for initiating, developing and executing the plan that created Verenium from the merger of two organizations. He integrated the organizations, raised approximately $200 million of incremental capital for the company and closed a unique strategic partnership with UK-based BP plc worth over $130 million of non-dilutive capital for the company. Prior to Verenium, he served as Senior Vice President and Chief Financial Officer for Xanthus Pharmaceuticals, Senior Vice President Corporate Development and Chief Financial Officer for Synta Pharmaceuticals, Executive Vice President, Chief Operating Officer and Chief Financial Officer for Exact Sciences, and President of the Managed Care Division for Concentra Managed Care.

Mr. McCarthy also worked in the Investment Banking Division of Morgan Stanley and graduated with a Bachelor of Science degree from Lehigh University and an MBA from Harvard Business School.

About Microbia: (www.Microbia.com)
Microbia, Inc. (formerly Microbia Precision Engineering), is an industrial biotechnology company that develops high-value, renewable specialty ingredients and biomaterials by applying its proprietary metabolic engineering to fermentation-based manufacturing. Microbia will develop and market its products through direct sales and strategic alliances, including an on-going multi-product joint development and commercialization agreement with Tate & Lyle. Carotenoids will be the first products launched from Microbia's diverse pipeline of natural specialty ingredients, biopolymers and other biomaterials. Microbia, Inc., based in Lexington, Massachusetts, was established in 2006 as an operationally independent subsidiary of Ironwood Pharmaceuticals, Inc.

# # #

Read the full story at http://www.prweb.com/releases/Microbia/McCarthy/prweb2718134.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Microban Partners With YogaDirect.com to Launch Yoga Mats With Zinc Antimicrobial Technology
2. BioNeutrals Ygiene(TM) Hospital Grade Antimicrobial Demonstrates a 99.9997% Kill Rate Against Clostridium Difficile Spores (C.diff) in Independent Lab Pre-testing Phase
3. Ganeden Biotech Introduces GanPro(TM) Direct-Fed Microbial for Livestock
4. Microbia, Inc. Names Alex Chu as Vice President of Process Development
5. MIT reels in RNA surprise with microbial ocean catch
6. Microbia, Inc. Names Mike Doyle as Senior Vice President and General Manager, Nutrition Ingredients
7. Celsis Introduces ReACT(TM) RNA-Based Microbial Detection Assays
8. Microtest Labs Offers Free Microbial Identification Testing, Free Shipping on Other Tests, to MD&M West Attendees
9. DiFUSION Technologies Completes Successful Testing of Antimicrobial Spinal Implant
10. Microbia PE Adds Nutritional Ingredient Industry Veteran Charles Walton to Senior Management Team
11. Microbia PE Bolsters Senior Management Team; Positions Company for Commercializing Proprietary Bioproducts
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Microbia Names John McCarthy to Senior Management Team
(Date:6/24/2016)... , ... June 24, 2016 , ... Researchers at the ... commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the subject ... it now. , Diagnostic biomarkers are signposts in the blood, lung fluid or ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... 2016 Houston Methodist Willowbrook Hospital has ... Association to serve as their official health care ... Willowbrook will provide sponsorship support, athletic training services, ... coaches, volunteers, athletes and families. "We ... Association and to bring Houston Methodist quality services ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
Breaking Biology Technology:
(Date:6/1/2016)... NEW YORK , June 1, 2016 ... Biometric Technology in Election Administration and Criminal Identification to ... According to a recently released TechSci Research report, " ... Sector, By Region, Competition Forecast and Opportunities, 2011 - ... $ 24.8 billion by 2021, on account of growing ...
(Date:5/20/2016)... MINNEAPOLIS , May 20, 2016  VoiceIt ... technology partnership with VoicePass. By working ... user experience.  Because VoiceIt and VoicePass take slightly ... two engines increases both security and usability. ... expressed excitement about this new partnership. ...
(Date:5/12/2016)... DALLAS , May 12, 2016 ... has just published the overview results from the Q1 ... of the recent wave was consumers, receptivity to a ... wearables data with a health insurance company. ... choose to share," says Michael LaColla , CEO ...
Breaking Biology News(10 mins):